Not lying, bottom line is this can be obtained as it is public information on what companies donate. RCA being the big fish in the retina sea can do what they want to identify the misgivings of our industry, they know they and many other large practices have an ear with pharma. As to who has rights to the funds, the fact is that industry cannot earmark where the money is spent and those who have donated in ophthalmology will see that the funds currently open have nothing to do with ophthalmology, it’s a sad state of affairs. Since DNA touts is free drug program as a “foundation”, which is far from the case, build market share, maybe the investigation needs to start poking around SSF??